OZ BIOSCIENCES
Filter By Industry
Filter By Tag
Newsroom |
OZ BIOSCIENCES Press releases
1 - 9 of 9 Press ReleasesSep 22, 2015
Awarded patent on Cationic lipids for transporting active agents into cells Marseille September 22 2015 - OZ BIOSCIENCES, a french biotech company specialized in the development of innovative transfection and transduction reagents, has been granted...
Jun 26, 2014
OZ BIOSCIENCES, a french biotech company specialized in the development of innovative transfection and transduction reagents, has just launched its new website.
Oct 14, 2013
OZ Biosciences is now opening its US office in San Diego, California.
Apr 23, 2013
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new mRNA transfection Reagents : RmesFect™ and RmesFect™ Stem.
Feb 21, 2013
DreamFect™ Stem transfection reagent from Oz Biosciences is specifically developed for transfection of Stem Cell.
Nov 16, 2012
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new products Mag4C Kits.
May 18, 2012
OZ Biosciences SAS, specialized in the development of innovative transfection technologies, further expands their comprehensive catalog with a new product line dedicated to In Vivo transfection and/infection.
Apr 02, 2012
Ideal for sensitive cell types such as primary and stem cells, the Viro-MICST™ reagent allows the efficient and specific transduction of target cells directly on magnetic cell-purification columns.
Jan 31, 2012
Magnetofectamine™ is the association of Lipofectamine™ 2000 the most renowned transfection reagent from Life Technologies Corporation (Invitrogen™) with the unique Magnetofection™ based reagent CombiMag, from OZ Biosciences™.